The stock of Oscar Health Inc (NYSE:OSCR) last traded at $17.00, down -5.61% from the previous session.
OSCR stock price is now -6.11% away from the 50-day moving average and -2.50% away from the 200-day moving average. The market capitalization of the company currently stands at $4.20B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $21 to $13.50, BofA Securities Downgraded its rating from Neutral to Underperform for Oscar Health Inc (NYSE: OSCR). On October 07, 2024, UBS recently initiated its ‘Neutral’ rating on the stock quoting a target price of $23, while ‘Piper Sandler’ rates the stock as ‘Overweight’
In other news, ELBERT O ROBINSON, Director bought 25,000 shares of the company’s stock on Nov 20 ’24. The stock was bought for $426,252 at an average price of $17.05. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 14 ’24, Director Thrive Partners VII Growth GP, bought 344,522 shares of the business’s stock. A total of $5,444,343 was incurred on buying the stock at an average price of $15.80. This leaves the insider owning 6,155,222 shares of the company worth $104.64 million. A total of 29.63% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $7.29 and a high of $23.79. The fifty day moving average price for OSCR is $18.1804 and a two-hundred day moving average price translates $17.4183 for the stock.
The latest earnings results from Oscar Health Inc (NYSE: OSCR) was released for 2024-09-30. The net profit margin was 0.35% and return on equity was 2.78% for OSCR. The company reported revenue of $2.42 billion for the quarter, compared to $1.44 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 68.3 percent.
